Which of the following auto antibodies is most likely to be present in a patient with systemic lupus erythematosus?
All are true about Sjogren syndrome except
A 45-year-old female presents with dry eyes, dry mouth, and joint pain. Which of the following antibodies is most indicative of the suspected condition?
Which is the rheumatoid arthritis autoantibody?
A 30-year-old woman presents with thyroid swelling. On investigations, her TSH levels are found to be elevated. Postoperative reports showed lymphocytic infiltration and Hurthle cells. A most probable diagnosis is?
Which of the following cardiac complications may develop in a 33 year old woman with systemic lupus erythematosus (SLE) because of her underlying condition?
Which is not an autoimmune disease
All are true about autoimmune disease except:
Which of the following is the most important infiltrate in rheumatoid arthritis?
Cell surface molecules involved in peripheral tolerance induction are
Explanation: ***Anti-ds DNA*** - **Anti-double-stranded DNA (anti-dsDNA)** antibodies are highly specific for **Systemic Lupus Erythematosus (SLE)** and are included in the classification criteria [1]. - Their levels often correlate with disease activity, especially in cases with **lupus nephritis** [1]. *Antiphospholipid* - While **antiphospholipid antibodies** can be present in SLE patients (leading to **secondary antiphospholipid syndrome**), they are not the most characteristic or diagnostic autoantibody for SLE itself. - These antibodies are primarily associated with a **prothrombotic state** and recurrent miscarriages. *Anti-Ro* - **Anti-Ro (SSA) antibodies** are associated with SLE, particularly with **cutaneous lupus**, **neonatal lupus**, and **Sjögren's syndrome**, but they are not as specific as anti-dsDNA for the general diagnosis of SLE [1]. - Patients with anti-Ro antibodies may have a higher risk of **photosensitivity** [1]. *Anti-RNP* - **Anti-RNP antibodies** are found in patients with SLE, but they are most characteristically associated with **Mixed Connective Tissue Disease (MCTD)**. - Their presence in SLE often correlates with less severe renal involvement but may indicate **myositis** or **Raynaud's phenomenon**.
Explanation: ***Subcutaneous fibrosis*** - **Subcutaneous fibrosis** is typically associated with conditions like **systemic sclerosis** or **eosinophilic fasciitis**, not Sjögren's syndrome [2]. - Sjögren's syndrome primarily affects exocrine glands and other organ systems, but **fibrosis of subcutaneous tissue** is not a characteristic manifestation. *Xerostomia* - **Xerostomia**, or **dry mouth**, is a hallmark symptom of Sjögren's syndrome due to immune-mediated destruction of salivary glands. - This symptom can lead to dental caries, dysphagia, and difficulty speaking. *Lack of tear* - **Keratoconjunctivitis sicca**, or **dry eyes** (lack of tears), is another cardinal feature of Sjögren's syndrome, resulting from inflammation of the lacrimal glands [1]. - Patients often experience grittiness, foreign body sensation, and blurred vision due to insufficient tear production. *Interstitial nephritis* - **Interstitial nephritis** can occur in Sjögren's syndrome, particularly **tubulointerstitial nephritis**, which may lead to **renal tubular acidosis**. - Renal involvement, though less common than sicca symptoms, is a recognized extraglandular manifestation.
Explanation: ***Anti-Ro/SSA antibodies*** - The patient's symptoms of **dry eyes (xerophthalmia)**, **dry mouth (xerostomia)**, and **joint pain** are classic manifestations of **Sjögren's syndrome**, a chronic autoimmune disease. [1] - **Anti-Ro/SSA antibodies** are highly specific for Sjögren's syndrome, particularly in patients with primary Sjögren's. [1] *Anti-histone antibodies* - These antibodies are most commonly associated with **drug-induced lupus erythematosus**, a condition characterized by lupus-like symptoms that develop after exposure to certain medications. - The clinical presentation of dry eyes and dry mouth is not the primary distinguishing feature of drug-induced lupus. *Anti-thyroid peroxidase antibodies* - These antibodies are a hallmark of **Hashimoto's thyroiditis**, an autoimmune disease affecting the thyroid gland and leading to hypothyroidism. [2] - While Sjögren's syndrome can coexist with other autoimmune conditions, anti-thyroid peroxidase antibodies do not directly indicate Sjögren's. *Anti-phospholipid antibodies* - These antibodies are primarily associated with **antiphospholipid syndrome**, a thrombophilic disorder characterized by arterial or venous thrombosis and/or adverse pregnancy outcomes. - They are not directly indicative of the sicca symptoms seen in Sjögren's syndrome.
Explanation: ***Anti CCP*** - **Anti-Citrullinated Protein Antibodies (CCP)** are highly specific for **rheumatoid arthritis** and are used for diagnosing this condition. - A positive **Anti-CCP** test can indicate the presence of **rheumatoid arthritis** even before clinical symptoms appear. *Anti histone* - This antibody is primarily associated with **drug-induced lupus erythematosus**, not rheumatoid arthritis. - It identifies a **response** to medications, rather than being a specific marker for a rheumatic condition like RA. *Anti DLE* - Suggests antibodies related to **discoid lupus erythematosus**, not rheumatoid arthritis. - These antibodies do not correlate with inflammatory joint disease or diagnosis of RA. *Anti ds DNA* - Commonly associated with **systemic lupus erythematosus** (SLE) rather than rheumatoid arthritis [1]. - While relevant for lupus, it lacks specificity for diagnosing rheumatic arthritis; ANA testing is noted as not useful in diagnosing RA specifically [1].
Explanation: ***Hashimoto's thyroiditis*** - The presence of **lymphocytic infiltration** and **Hurthle cells** on postoperative pathology is characteristic of Hashimoto's thyroiditis [1,2]. - Elevated **TSH levels** indicate hypothyroidism, which aligns with the autoimmune nature of Hashimoto's affecting thyroid hormone production [1]. *Graves disease* - Typically presents with **hyperthyroidism**, leading to suppressed TSH levels rather than elevation. - Characterized by **thyroid enlargement** and the presence of **autoantibodies** like TSI, not lymphocytic infiltration. *Follicular carcinoma* - While it can cause **thyroid swelling**, it is usually associated with **malignant characteristics** rather than Hurthle cells and lymphocytic infiltration. - TSH levels can be normal, as it does not principally engage in autoimmune thyroid destruction like Hashimoto's. *Medullary carcinoma thyroid* - Originates from **C cells** producing calcitonin, and typically presents with elevated calcitonin levels, not TSH. - Characteristic findings include **C-cell hyperplasia** or **neoplastic changes**, which do not match the presented lymphocytic infiltration. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1090-1092. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 427-428.
Explanation: ***Libman-Sacks endocarditis*** - Libman-Sacks endocarditis is a **non-infectious valvular vegetation** that is highly characteristic of **systemic lupus erythematosus (SLE)** [3]. - These vegetations can lead to **valvular incompetence** or **stenosis**, primarily affecting the **mitral and aortic valves** [1]. *Mitral valve prolapse* - While mitral valve prolapse can occur in SLE patients, it is a relatively common condition in the general population and is **not as specifically linked** to SLE pathology as Libman-Sacks endocarditis. - It involves the **leaflet(s) of the mitral valve bulging** back into the left atrium during systole, which causes a **mid-systolic click and late systolic murmur**, but does not represent the specific immune-mediated damage seen in SLE. *Hemorrhagic pericarditis* - Pericarditis is a common cardiac manifestation in SLE, leading to **inflammation of the pericardium**, but it is typically **serous or fibrinous**, not usually hemorrhagic. - **Hemorrhagic pericarditis** is more often associated with conditions like malignancy, tuberculosis, or trauma, and is not a typical presentation of SLE. *Infective endocarditis* - **Infective endocarditis** is caused by microbial infection of the heart valves, resulting in **vegetations containing bacteria or fungi** [2]. - While SLE patients can be at increased risk for infections due to immunosuppression, the vegetations of Libman-Sacks endocarditis are **sterile (non-infectious)** and distinct in their underlying pathophysiology [1].
Explanation: ***Sickle cell disease*** - This is a **genetic disorder** caused by a mutation in the **beta-hemoglobin gene**, leading to abnormal hemoglobin (hemoglobin S) and sickle-shaped red blood cells. - It is an **inherited blood disorder**, not an autoimmune condition where the immune system attacks the body's own tissues. *SLE (Systemic Lupus Erythematosus)* - SLE is a **chronic autoimmune connective tissue disease** that can affect multiple organ systems. - It is characterized by the production of **autoantibodies** against various self-antigens, such as anti-dsDNA and anti-Sm antibodies. *Grave's disease* - This is an **autoimmune disorder** that leads to **hyperthyroidism**. - It is caused by the production of **autoantibodies** (thyroid-stimulating immunoglobulins) that mimic TSH and stimulate the thyroid gland to produce excessive thyroid hormones. *Myasthenia Gravis* - Myasthenia Gravis is an **autoimmune neuromuscular disease** characterized by fluctuating muscle weakness. - It is caused by **autoantibodies** that block or destroy acetylcholine receptors at the neuromuscular junction, impairing nerve-to-muscle communication.
Explanation: ***Higher incidence among males*** - Autoimmune diseases (Ads) generally have a **higher incidence among females** than males, challenging the statement that they are more common in males [1]. - For example, conditions like **Systemic Lupus Erythematosus (SLE)** and **Rheumatoid Arthritis (RA)** show a pronounced female predominance [1]. *T cells recognize self-antigen* - This statement is true; in autoimmune diseases, **autoreactive T cells** fail to undergo proper selection and differentiation, leading them to recognize and attack **self-antigens** [2]. - This recognition often mediates tissue damage, as seen in **Type 1 Diabetes** where T cells target pancreatic beta cells [2]. *Polyclonal B cell activation* - This is also true; autoimmune diseases often involve **polyclonal B cell activation**, leading to the production of various **autoantibodies** that target self-components. - This broad activation contributes to the diverse clinical manifestations and systemic nature of many autoimmune conditions like **Systemic Lupus Erythematosus**. *Hashimoto's thyroiditis is an example* - This statement is true; **Hashimoto's thyroiditis** is a classic example of an **organ-specific autoimmune disease** where autoantibodies and autoreactive T-cells attack thyroid gland components [3]. - It results in **hypothyroidism** due to chronic inflammation and gradual destruction of thyroid follicles [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 175-178. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 176-177. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1089-1090.
Explanation: ***Macrophages*** - **Macrophages** are crucial in rheumatoid arthritis synovium due to their role in producing **pro-inflammatory cytokines** like TNF-̑, IL-1, and IL-6, which drive joint destruction [1], [2]. - They also contribute to the **pannus formation** and degrade cartilage and bone through the release of proteases [1]. *Dendritic cells* - While present in the synovium, **dendritic cells primarily function as antigen-presenting cells**, initiating T-cell responses. - Their direct contribution to tissue damage and chronic inflammation is less prominent than that of macrophages. *CD4+ Helper cells* - **CD4+ T helper cells** orchestrate the immune response by activating B cells and macrophages, but they are not the primary effector cells causing direct tissue damage [3]. - They secrete cytokines that promote inflammation but do not directly participate in tissue degradation. *Neutrophils* - **Neutrophils are abundant in the synovial fluid** during acute flares, contributing to inflammation and breakdown of cartilage through the release of enzymes. - However, their role in the chronic, sustained synovial inflammation and tissue destruction characteristic of RA is less significant compared to macrophages. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 677-678. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 105-106. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, p. 1212.
Explanation: ***B7 and CD28*** - B7 is crucial for providing a **costimulatory signal** to T cells via interaction with CD28, promoting **T cell activation** and peripheral tolerance [1][2]. - This interaction is essential in preventing autoimmune responses by ensuring T cells require both antigen and costimulatory signals for full activation [1][3]. *B7 and CD3* - CD3 is a part of the T cell receptor (TCR) complex, primarily involved in **T cell activation**, not specifically in peripheral tolerance. - The interaction of B7 with **CD3** does not provide the costimulatory signal necessary for peripheral tolerance [3]. *CD34 and CD51* - CD34 is primarily involved in **hematopoietic stem cell trafficking** and does not play a role in T cell tolerance mechanisms. - CD51 is associated with **integrins** and plays a role in adhesion rather than in peripheral tolerance induction. *CD40 and CD40L* - While CD40-CD40L interactions are important for **B cell activation** and other immune responses, they are not directly involved in the inductive mechanisms of **peripheral tolerance** in T cells. - They primarily mediate costimulatory signals in **adaptive immunity**, not specifically for tolerance purposes. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 204-206. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 157-158. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 176-177.
Get full access to all questions, explanations, and performance tracking.
Start For Free